Literature DB >> 21290086

Serious adverse events reporting on systemic terbinafine: a Danish register-based study.

Nannie Bangsgaard, Ditte Marie Saunte, Maja Folkenberg, Claus Zachariae.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21290086     DOI： 10.2340/00015555-1041

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

1.  VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.

Authors:  E P Garvey; W J Hoekstra; W R Moore; R J Schotzinger; L Long; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

2.  Aplastic anemia associated with oral terbinafine: a case report and review of the literature.

Authors:  Bülent Kantarcıoğlu; Hüseyin Kemal Türköz; Güven Yılmaz; Funda Pepedil Tanrıkulu; Işık Kaygusuz Atagündüz; Cafer Adıgüzel; Tülin Fıratlı Tuğlular
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

3.  Treatment of onychomycosis using a 1064-nm diode laser with or without topical antifungal therapy: a single-center, retrospective analysis in 56 patients.

Authors:  G C Weber; P Firouzi; A M Baran; E Bölke; H Schrumpf; B A Buhren; B Homey; P A Gerber
Journal:  Eur J Med Res       Date:  2018-10-24       Impact factor: 2.175

4.  ACE-Inhibitor Related Angioedema Is Not Sufficiently Reported to the Danish Adverse Drug Reactions Database.

Authors:  Johan Emil Lundbek Cornwall; Anette Bygum; Eva Rye Rasmussen
Journal:  Drug Healthc Patient Saf       Date:  2019-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.